CNS Pharmaceuticals, Inc.

CNSP

Healthcare|Biotechnology|US

$3.92

-0.09 (-2.24%)

DCF Value

$7.67

Tangible Book / Share

$2.66

Cash / Share

$2.92

Clinical Trials (26)

Trial	Conditions	Phase	Status	Enrollment	Design	Drug
NCT03669315 Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation	Gambling Disorder	P3	Recruiting	40	RCT, Double-blind	—
NCT04762069 A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme	Glioblastoma Multiforme, Adult	P2	Active	252	RCT, Single-blind	Berubicin, Lomustine
NCT02783833 MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B	Malaria	P1P2	Completed	15	Open-label	MMV390048 40mg, MMV390048 dose to be determined mg
NCT02431650 Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent	Malaria	P1P2	Completed	11	RCT, Open-label	OZ439, Primaquine
NCT02385760 CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris	Acne Vulgaris	P2	Completed	124	RCT, Double-blind	CTX-4430, Placebo
NCT03880474 Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults	Influenza	P2	Terminated	2,364	RCT, Double-blind	MVA-NP+M1, Saline
NCT00302731 Bioidentical 'Natural' Hormone Evaluation in Early Menopause	Menopause	P2	Terminated	21	RCT, Double-blind	Estradiol , estriol , progesterone, estradiol, progesterone, estriol, progesterone, equine estrogens m-progesteroneacetate
NCT02573857 A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection	Malaria	P1P2	Terminated	16	Open-label	DSM265, OZ439
NCT03211221 rTMS Over the Supplementary Motor Area for Treatment-resistant Obsessive-compulsive Disorder.	Obsessive-Compulsive Disorder	P1P2	Unknown	30	RCT, Double-blind	—
NCT00284427 Safety of Antioxidants During GYN Cancer Care	Ovarian Cancer, Cervical Cancer	P2	Completed	25	Open-label	vitamin C
NCT01769027 Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS	Pandas	P2	Withdrawn	—	RCT, Double-blind	Sertraline+Antibiotic (penicillin/azithromycin), Sertraline+placebo, IVIG
NCT00228319 Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants	Ovarian Cancer	P1P2	Completed	27	RCT, Open-label	Paclitaxel, Carboplatin, Sodium Ascorbate
NCT02389348 A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265	Malaria	P1P2	Completed	13	Open-label	DSM265, OZ439
NCT02867059 SJ733 Induced Blood Stage Malaria Challenge Study	Plasmodium Falciparum Malaria	P1	Completed	17	Open-label	(+)-SJ000557733
NCT03748836 Adult Healthy Volunteers Study to Evaluate ALPN-101 Safety	Healthy Volunteers	P1	Completed	96	RCT, Double-blind	ALPN-101, Placebo
NCT04092751 Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy Subjects	Pharmacokinetics	P1	Completed	28	RCT, Open-label	PRA, SCY-078 plus PRA
NCT03542149 Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP	Malaria	P1	Completed	24	RCT, Open-label	480 mg Piperaquine phosphate, 640 mg Piperaquine phosphate, 200 mg OZ 439, 400 mg OZ 439, 800 mg OZ 439, 960 mg PQP, 320 mg PQP
NCT04092725 Study to Evaluate the Effect of SCY-078 on the PK of Dabigatran in Healthy Subjects	Pharmacokinetics	P1	Completed	36	RCT, Open-label	DAB, SCY-078 plus DAB
NCT01364805 New Treatment Option for Pancreatic Cancer	Pancreatic Cancer	P1	Completed	14	Open-label	Intravenous Vitamin C, Gemcitabine
NCT03792308 A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR206 in Healthy Volunteers	Healthy Volunteers	P1	Completed	94	RCT, Double-blind	SPR206, Placebo
NCT02783820 Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A	Malaria	P1	Completed	24	RCT, Double-blind	MMV390048 40 mg, Placebo to match MMV390048 40 mg, MMV390048 80 mg, Placebo to match MMV390048 80 mg, MMV390048 120 mg, Placebo to match MMV390048 120 mg
NCT02431637 Experimental Falciparum Transmission to Anopheles	Malaria	P1	Completed	6	Open-label	Administration of the malaria inoculum, Piperaquine Phosphate 480 mg
NCT03164018 Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis	Multiple Sclerosis		Completed	111	—	Fampridine
NCT03101735 Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece	RRMS		Completed	455	—	Dimethyl Fumarate (DMF)
NCT05752422 Transcranial Photobiomodulation for Adult ADHD	ADHD	N/A	Unknown	32	RCT, Double-blind	—
NCT02232165 Mean Arterial Blood Pressure Treatment for Acute Spinal Cord Injury	Acute Spinal Cord Injury	N/A	Terminated	17	RCT, Double-blind	—